Comparative trial of propranolol and practolol in hyperthyroidism.

The possible role of practolol in the management of hyperthyroidism has been studied by comparing it with propranolol. 2. In a double-blind cross-over trial, propranolol (40 mg), practolol (120 mg) and a placebo four times daily for one week were compared in twenty-one hyperthyroid patients by sequential analysis. 3. Judged by their effect on the symptoms and signs of thyrotoxicosis, both propranolol and practolol were significantly better than the placebo but no clear distinction could be made between the two active compounds. 4. Propranolol and practolol reduced heart rate by 24 and 17% respectively compared with placebo. 5. Patients generally preferred propranolol or practolol to placebo but this preference did not achieve significance with either drug. 6. Only in its effect on heart rate was practolol significantly inferior to propranolol, and it would appear to be a useful alternative to propranolol in the management of the peripheral manifestations of hyperthyroidism.

[1]  D. Shand.  Individualization of propranolol therapy. , 1974, The Medical clinics of North America.

[2]  R. Shanks,et al.  Blood levels of practolol after oral and parenteral administration and their relationship to exercise heart rate , 1974, Clinical pharmacology and therapeutics.

[3]  R. Shanks,et al.  The assessment of β-adrenoceptor blocking drugs in hyperthyroidism. , 1974, British journal of clinical pharmacology.

[4]  B. Joffe,et al.  Adrenergic-Blocking Drugs in Hyperthyroidism , 1973 .

[5]  P. Turner.  Oxprenolol in thyrotoxicosis. , 1973, Lancet.

[6]  B. Scazziga,et al.  Effect of pindolol, a beta receptor antagonist, in hyperthyroidism , 1973, Clinical pharmacology and therapy.

[7]  B. Pimstone,et al.  Practolol in hyperthyroid cardiac failure. , 1971, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

[8]  D. Shand,et al.  Plasma Propranolol Levels in the Quantitative Assessment of β-adrenergic Blockade in Man , 1970, British medical journal.

[9]  D. Hadden,et al.  Controlled trial of propranolol in thyrotoxicosis. , 1969, Lancet.

[10]  R G Shanks,et al.  Comparison of the effects of I.C.I. 50172 and propranolol on the cardiovascular responses to adrenaline, isoprenaline and exercise , 1968, British journal of pharmacology.

[11]  P. Turner,et al.  A comparison of three beta-adrenergic receptor-blocking drugs in thyrotoxic tachycardia. , 1968, The Journal of clinical pharmacology and the journal of new drugs.

[12]  P. Turner.  Beta-adrenergic receptor blocking drugs in hyperthyroidism. , 1974, Drugs.